BAYER PHARMA AG - Germany 

This institution has been merged with: BAYER.

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 11
As coordinator: 0
As participant: 11
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 32.200.000 0 2
2016 0 21.085.937 0 2
2015 0 6.463.625 498.433 2
2014 0 4.000.000 400.000 1
2013 0 3.935.721 95.400 1
2011 0 12.766.589 638.857 3

Networking:

Partners:

Institution:Projects [No]:
MEDIZINISCHE UNIVERSITAET WIEN4
GENOME RESEARCH3
JANSSEN PHARMACEUTICA NV3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
ABBVIE INC2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTELLAS PHARMA EUROPE BV2
CANCER RESEARCH UK2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KATHOLIEKE UNIVERSITEIT LEUVEN2
LUNDS UNIVERSITET2
MERCK SHARP & DOHME CORP2
NOVARTIS PHARMA2
NOVO NORDISK2
PFIZER LIMITED2
SANOFIAVENTIS DEUTSCHLAND2
TAKEDA DEVELOPMENT CENTRE EUROPE2
UNIVERSIDAD DE NAVARRA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF LEEDS2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF TURKU2
ABBVIE1
ABBVIE DEUTSCHLAND GMBH & CO KG1
ACTELION PHARMACEUTICALS1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AMGEN1
AMGEN LIMITED1
ANTAROS MEDICAL AB1
ASSOCIATION POUR LA RECHERCHE DE THERAPEUTIQUES INNOVANTES EN CANCEROLOGIE1
ASTRAZENECA AB1
AXCENTUA PHARMACEUTICALS AB1
BARTS AND THE LONDON NHS TRUST1
BIOXYDYN LIMITED1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRUKER BIOSPIN MRI1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CELGENE MANAGEMENT SARL1
CHALMERS TEKNISKA HOEGSKOLA AB1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CHU HOPITAUX DE BORDEAUX1
CONCENTRIS RESEARCH MANAGEMENT1
CSL BEHRING1
DANMARKS TEKNISKE UNIVERSITET1
ERASMUS UNIVERSITEIT ROTTERDAM1
ERNSTMORITZARNDTUNIVERSITAET GREIFSWALD1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN PATIENTS' FORUM1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
EXPERIMENTAL PHARMACOLOGY AND ONCOLOGY BERLINBUCH1
F HOFFMANNLA ROCHE1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION HOSPITAL LA FE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GE HEALTHCARE LIMITED1
GILUPI1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GMV SOLUCIONES GLOBALES INTERNET SAU1
GPOH GEMEINNUTZIGE1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
GROUPE FRANCOPHONE DES MYELODYSPLASIES1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HORIZON DISCOVERY LIMITED1
IKERLAN SCOOP1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT CURIE1
INSTITUT FUER PHOTONISCHE TECHNOLOGIEN EV1
INSTITUT GUSTAVE ROUSSY1
INSTITUTO DE MEDICINA MOLECULAR1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS1
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI1
ISTITUTO EUROPEO DI ONCOLOGIA1
ITASUOMEN YLIOPISTO1
JDRF INTERNATIONAL1
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN1
KAROLINSKA INSTITUTE1
KLINIKUM DER UNIVERSITAET REGENSBURG1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
KUNGLIGA TEKNISKA HOEGSKOLAN1
LAB 21 LIMITED1
LANCASTER UNIVERSITY1

Constancy:

Total number of partners: 206
Partner loyalty:
Frequent Partner: (> 2 projects): 13
Rare Partner: 193
Frequent / Rare Partner Ratio: 0.07

Project overview: